Ayala Pharmaceuticals Inc (ADXS)

[cab033]

ADXS should NOT extend the expiration of the Warrants! Every warrant holder had the opportunity for a 2,000%+ ROI if they bought in the open market early on and pure profit if they were involved in the original offering. If the company has the possibility of releasing Phase III data in 2020, then extending the warrants to expire in that year is NOT in the best interest of the shareholders. That would dilute the company roughly 6-7% if they did that. How would SH's feel about that? This MB looses it when they dilute 5% to pay employees, so why would they be any happier watching more dilution to pay a few warrant holders a larger profit?